- Net Sales: ¥2.71B
- Operating Income: ¥20M
- Net Income: ¥36M
- EPS: ¥20.20
| Item | Current | Prior | YoY % |
|---|
| Net Sales | ¥2.71B | ¥2.17B | +25.0% |
| Cost of Sales | ¥1.57B | - | - |
| Gross Profit | ¥597M | - | - |
| SG&A Expenses | ¥567M | - | - |
| Operating Income | ¥20M | ¥30M | -33.3% |
| Non-operating Income | ¥26M | - | - |
| Non-operating Expenses | ¥5M | - | - |
| Ordinary Income | ¥44M | ¥51M | -13.7% |
| Profit Before Tax | ¥50M | - | - |
| Income Tax Expense | ¥14M | - | - |
| Net Income | ¥36M | - | - |
| Net Income Attributable to Owners | ¥50M | ¥35M | +42.9% |
| Total Comprehensive Income | ¥31M | ¥48M | -35.4% |
| Interest Expense | ¥5M | - | - |
| Basic EPS | ¥20.20 | ¥14.17 | +42.6% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|
| Current Assets | ¥3.54B | ¥3.57B | ¥-32M |
| Cash and Deposits | ¥2.40B | ¥2.30B | +¥101M |
| Accounts Receivable | ¥190M | ¥197M | ¥-7M |
| Non-current Assets | ¥197M | ¥233M | ¥-36M |
| Property, Plant & Equipment | ¥58M | ¥68M | ¥-10M |
| Item | Value |
|---|
| Net Profit Margin | 1.8% |
| Gross Profit Margin | 22.0% |
| Current Ratio | 185.2% |
| Quick Ratio | 185.2% |
| Debt-to-Equity Ratio | 1.08x |
| Interest Coverage Ratio | 4.43x |
| Effective Tax Rate | 28.8% |
| Item | YoY Change |
|---|
| Net Sales YoY Change | +25.0% |
| Operating Income YoY Change | -30.4% |
| Ordinary Income YoY Change | -13.5% |
| Net Income Attributable to Owners YoY Change | +42.5% |
| Total Comprehensive Income YoY Change | -36.5% |
| Item | Value |
|---|
| Shares Outstanding (incl. Treasury) | 2.52M shares |
| Treasury Stock | 466 shares |
| Average Shares Outstanding | 2.52M shares |
| Book Value Per Share | ¥712.55 |
| Item | Amount |
|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥8.00 |
| Segment | Revenue | Operating Income |
|---|
| LifeAssistance | ¥359M | ¥81M |
| MedicalAssistance | ¥2.35B | ¥348M |
| Item | Forecast |
|---|
| Net Sales Forecast | ¥3.60B |
| Operating Income Forecast | ¥50M |
| Ordinary Income Forecast | ¥75M |
| Net Income Attributable to Owners Forecast | ¥67M |
| Basic EPS Forecast | ¥26.59 |
This data was automatically extracted from XBRL files. Please refer to the original disclosure documents for accuracy.
Verdict: Strong topline growth but margin compression and reliance on non-operating gains led to weak operating profitability in FY2025 Q3. Revenue surged 25.0% YoY to 27.12, while operating income fell 30.4% YoY to 0.20, indicating negative operating leverage. Gross profit was 5.97 with a gross margin of 22.0%, but SG&A of 5.67 absorbed nearly all gross profit, yielding a slim operating margin of 0.74%. Ordinary income declined 13.5% YoY to 0.44, supported by non-operating income of 0.26 (notably 0.03 of interest income) and limited non-operating expenses of 0.05. Net income rose 42.5% YoY to 0.50, implying favorable below-ordinary items and/or tax effects despite operating weakness. Operating margin compressed by approximately 58 bps YoY (from ~1.32% to 0.74%), and ordinary margin compressed by roughly 72 bps YoY (from ~2.34% to 1.62%). Conversely, net margin improved by about 22 bps to 1.84%, highlighting the non-operating boost. ROE stood at 2.8%, with DuPont showing a modest asset turnover (0.725x) and low net margin (1.8%) as the primary drag; financial leverage is moderate at 2.08x. ROIC is 3.0%, below the 5% warning threshold, flagging capital efficiency concerns. Liquidity is ample (current ratio 185.2%, cash 24.03 vs short-term loans 10.80), but interest coverage at 4.43x is below the 5x comfort threshold. Earnings quality cannot be assessed robustly as cash flow statements were unreported; OCF/NI and FCF are N/A. Dividend payout ratio is indicated at 40.3%, suggesting nominal earnings cover, but FCF coverage is unknown. Forward-looking, sustaining revenue growth will require cost discipline to restore operating margin, while reducing dependence on non-operating income. Balance sheet strength (high cash) mitigates near-term refinancing risk, but structurally low margins and ROIC must improve for value creation. Key watchpoints are SG&A efficiency, pricing power, and stabilization of non-operating contributions.
ROE decomposition (DuPont): 2.8% ROE = 1.8% Net Profit Margin × 0.725x Asset Turnover × 2.08x Financial Leverage. The margin component is the dominant constraint on ROE, given a very low operating margin (0.74%) and heavy reliance on non-operating income (non-operating income ratio 52.6%). Business drivers: rapid revenue growth (+25.0% YoY) did not scale through SG&A (5.67 nearly matched gross profit of 5.97), suggesting either wage inflation, staffing expansion, or acquisition/onboarding costs that outpaced gross profit growth. Ordinary income benefitted from non-operating items (0.26) offsetting operating weakness, while interest expense (0.05) compressed the spread. Sustainability: the net margin uplift vs prior year appears driven by below-ordinary items and tax effects rather than core operations, thus less repeatable; operating margin recovery would require SG&A efficiency and/or better gross margin. Concerning trends: operating income down 30.4% YoY despite strong sales, indicating negative operating leverage; non-operating dependency elevated; ROIC at 3.0% is subpar relative to a typical 6–8% implied cost of capital.
Revenue growth was robust at +25.0% YoY to 27.12, indicating healthy demand recovery/expansion in assistance services. However, operating income declined 30.4% YoY to 0.20, highlighting cost pressure and weak operating leverage. Ordinary income fell 13.5% YoY to 0.44, partly cushioned by non-operating gains (0.26) relative to small non-operating expenses (0.05). Net income rose 42.5% YoY to 0.50, implying supportive non-operating/tax items; effective tax rate is shown at 28.8%, but reported PBT (0.50) vs NI (0.50) suggests potential below-tax adjustments—data limitations apply. Profit quality is mixed: core operations are soft, while net profit benefited from non-operating factors. Sustainability hinges on SG&A control and gross margin stabilization; without that, further revenue growth may not translate to earnings. Near-term outlook: focus on cost discipline, pricing/mix improvement, and reducing reliance on non-operating items to normalize ordinary and net margins.
Liquidity is strong: current ratio 185.2% and quick ratio 185.2%, with cash and deposits of 24.03 covering 1.26x current liabilities (19.13). Solvency is acceptable: D/E 1.08x and an estimated equity ratio around 48% (equity 17.95 / assets 37.39). Interest coverage of 4.43x is below the 5x comfort benchmark, flagging sensitivity to earnings volatility or rate increases. Maturity profile risk: short-term loans total 10.80 versus cash 24.03; refinancing risk is mitigated by cash on hand, but reliance on short-term funding remains a consideration. No off-balance sheet obligations were disclosed in the provided data. Current ratio is comfortably >1.0 and D/E <2.0; no explicit covenant stress indicated.
Operating cash flow, investing cash flow, and free cash flow were unreported, so OCF/Net Income and FCF coverage cannot be assessed. As such, earnings quality cannot be validated via cash conversion metrics (OCF/NI benchmark >1.0). Working capital indicators: accounts receivable are modest at 1.90 against revenue of 27.12, but without period averages or payables/inventory dynamics, we cannot infer deliberate working capital timing effects. With interest coverage at 4.43x and low operating margin, strong cash conversion is important; absence of OCF data is a key limitation.
The calculated payout ratio is 40.3%, which is within a generally sustainable range (<60%), but FCF coverage is unknown due to unreported cash flows. With cash and deposits of 24.03 and working capital of 16.30, near-term dividend capacity appears supported by balance sheet liquidity. However, structurally low ROIC (3.0%) and weak operating margins suggest that maintaining or growing dividends long term should be contingent on improving core cash generation and reducing non-operating reliance. No information on DPS progression or buybacks was disclosed.
Business Risks:
- Margin compression from SG&A growth outpacing gross profit amid rapid revenue expansion
- Dependence on non-operating income to sustain ordinary and net profit
- Potential wage inflation and staffing costs in assistance/call-center operations
- FX exposure related to overseas assistance and cross-border medical payments
- Customer/partner concentration risk with insurers/travel agencies (typical for the industry)
Financial Risks:
- Interest coverage at 4.43x below strong threshold, raising sensitivity to rate hikes or earnings shocks
- Short-term debt reliance (10.80) despite strong cash; rolling risk if cash is redeployed
- Low ROIC at 3.0% risks value dilution if growth requires incremental capital
- Cash flow opacity: OCF/FCF unreported, limiting assessment of dividend and capex coverage
Key Concerns:
- ROIC 3.0% (<5% warning) indicates poor capital efficiency
- Operating margin 0.74% with negative operating leverage despite +25% revenue growth
- Non-operating income ratio 52.6% underscores earnings quality risk
- Interest coverage below 5x
- Data limitations on cash flows and SG&A breakdown obscure underlying drivers
Key Takeaways:
- Topline momentum is strong (+25% YoY), but core profitability weakened materially
- Net income growth (+42.5% YoY) is not fully reflective of operating strength due to non-operating support
- Liquidity is ample; refinancing risk is contained near term, though operating resilience must improve
- Capital efficiency (ROIC 3.0%) is below cost-of-capital norms—improvement is critical for value creation
- Monitoring cost discipline and the mix of operating vs non-operating earnings is essential
Metrics to Watch:
- Operating margin and ordinary margin progression (bps changes QoQ/YoY)
- SG&A-to-sales ratio and any disclosed cost initiatives
- Non-operating income share of ordinary profit
- ROIC vs management targets, and drivers (NOPAT, invested capital efficiency)
- OCF/Net Income and FCF once reported
- Interest coverage and short-term debt levels
- Effective tax rate stability and any extraordinary items
Relative Positioning:
Within Japan-listed assistance/medical support peers, the company shows above-average liquidity but below-average operating margin and ROIC; earnings are more sensitive to non-operating items than peers with stronger core profitability.
This analysis was auto-generated by AI. Please note the following:
- No Guarantee of Accuracy: The accuracy and completeness of this analysis are not guaranteed. For accurate financial data, please refer to the original disclosure documents published on TDnet or other official sources
- Not Investment Advice: This analysis is for general informational purposes only and does not constitute investment advice under applicable securities laws. It is not a recommendation to buy or sell any specific securities
- At Your Own Risk: Investment decisions should be made at your own discretion and risk. We assume no liability for any losses incurred based on this analysis